Jaxteran
On the Bulgarian pack: Джакстеран 240 mg стомашно-устойчиви твърди капсули
240 mg · gastro-resistant capsule, hard
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Dimethyl fumarate
- Made by
- Zentiva k.s
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (dimethyl fumarate). It describes the substance, not this Bulgarian product — its uses and doses can differ.
The mechanism by which dimethyl fumarate (DMF) exerts its therapeutic effect in multiple sclerosis is unknown.
DMF and the metabolite, monomethyl fumarate (MMF), have been shown to activate the Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway in vitro and in vivo in animals and humans.
In humans, dimethyl fumarate is extensively metabolized by esterases, which are ubiquitous in the gastrointestinal tract, blood, and tissues, before it reaches the systemic circulation.
Following administration of dimethyl fumarate delayed-release capsules 240 mg twice a day with food, the mean C max of MMF was 1.87 mg/L and AUC was 8.21 mg.hr/L in MS patients.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-10-30
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (dimethyl fumarate). It describes the substance, not this Bulgarian product — its uses and doses can differ.
- Dimethyl fumarate delayed-release capsules are contraindicated in patients with known hypersensitivity to dimethyl fumarate or to any of the excipients of dimethyl fumarate delayed-release capsules.
- Reactions have included anaphylaxis and angioedema [see Warnings and Precautions ( 5.1 )].
- Known hypersensitivity to dimethyl fumarate or any of the excipients of dimethyl fumarate delayed-release capsules.
Most common adverse reactions (incidence ≥10% and ≥2% placebo) were flushing, abdominal pain, diarrhea, and nausea.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States19 matching products
European UnionNo exact match for this strength and form
Spain28 matching products
- FUMARATO DE DIMETILO ACCORD 240 MG · cápsula dura gastrorresistente2 makers
- FUMARATO DE DIMETILO MYLAN 240 mg · cápsula dura gastrorresistente2 makers
- FUMARATO DE DIMETILO NEURAXPHARM 240 mg · cápsula dura gastrorresistente2 makers
- DIMFORDA 240 mg · cápsula dura gastrorresistente
- FUMARATO DE DIMETILO AUROVITAS 240 mg · cápsula dura gastrorresistente
- FUMARATO DE DIMETILO CIPLA 240 mg · cápsula dura gastrorresistente
- FUMARATO DE DIMETILO DR. REDDYS 240 MG · cápsula dura gastrorresistente
- FUMARATO DE DIMETILO GLENMARK 240 mg · cápsula dura gastrorresistente
Canada7 matching products
- APO-DIMETHYL FUMARATE 240 mg · capsule (delayed-release)
- AURO-DIMETHYL FUMARATE 240 mg · capsule (delayed-release)
- GLN-DIMETHYL FUMARATE 240 mg · capsule (delayed-release)
- JAMP DIMETHYL FUMARATE 240 mg · capsule (delayed-release)
- PMS-DIMETHYL FUMARATE 240 mg · capsule (delayed-release)
- SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES 240 mg · capsule (delayed-release)
- TECFIDERA 240 mg · capsule (delayed-release)
Netherlands23 matching products
- Dimethylfumaraat Sandoz 240 mg 240 mg · maagsapresistente capsule, hard2 makers
- Dimethylfumaraat Teva 240 mg 240 mg · maagsapresistente capsule, hard2 makers
- Dimethylfumaraat Abdi 240 mg maagsapresistente capsules 240 mg · maagsapresistente capsule, hard
- Dimethylfumaraat Accord 240 mg harde maagsapresistente capsules 240 mg · maagsapresistente capsule, hard
- Dimethylfumaraat Aurobindo 240 mg 240 mg · maagsapresistente capsule, hard
- Dimethylfumaraat Biocon 240 mg 240 mg · maagsapresistente capsule, hard
- Dimethylfumaraat CF 240 mg 240 mg · maagsapresistente capsule, hard
- Dimethylfumaraat Glenmark 240 mg harde maagsapresistente capsules 240 mg · maagsapresistente capsule, hard
SwitzerlandNo exact match for this strength and form
Details
| Made by | Zentiva k.s · Czech Republic |
|---|---|
| Active substance | Dimethyl fumarate |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 240 mg |
| Form | gastro-resistant capsule, hard |
| Pack sizes | 56 · 100 · 168 |
| Classification | L04AX07 · Cancer treatments and immune-system medicines |
| Name in the register | Джакстеран 240 mg стомашно-устойчиви твърди капсули |
| Reg. no. | 20230074 |
Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician
Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- gastro-resistant capsule, hard2 products
- 120 mg
- 240 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.